Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gonadal dysfunction in male long-term survivors of malignant lymphoma
2020-002140-22Phase 2Completed
- Sponsor
- Lars møller Pedersen
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of testosterone in Hypogonadism, testicular failure and gonadal disease, sponsored by Lars møller Pedersen. Primary endpoint: Effect of testosterone on global quality of life (QLQ-C30). Started Jun 2020; status: completed.
02
Drugs
testosterone
03
Conditions
Hypogonadismtesticular failuregonadal disease
Beyond the preview
Go deeper on 2020-002140-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002140-22.